Astrid Hoermann

Astrid Hoermann

Auto-generated profile, based on publicly available information

Astrid Hoermann

Department of Life Sciences, Imperial College London, London, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Science Advances
Verified
Journal Article
Open access
AHAstrid Hoermann
Astrid Hoermann
THTibebu Habtewold
Tibebu Habtewold
PSPrashanth Selvaraj
Prashanth Selvaraj
GCGiuseppe Del Corsano
Giuseppe Del Corsano
PCPaolo Capriotti
Paolo Capriotti
NWNikolai Windbichler
Nikolai Windbichler
Gene drives hold promise for the genetic control of malaria vectors. The development of vector population modification strategies hinges on the availability of effector mechanisms impeding parasite development in transgenic mosquitoes. We augmented a midgut gene of the malaria mosquito Anopheles gambiae to secrete two exogenous antimicrobial peptides, magainin 2 and melittin. This small genetic modification, capable of efficient nonautonomous gene drive, hampers oocyst development in both Plasmodium falciparum and Plasmodium berghei . It delays the release of infectious sporozoites, while it simultaneously reduces the life span of homozygous female transgenic mosquitoes. Modeling the spread of this modification using a large-scale agent-based model of malaria epidemiology reveals that it can break the cycle of disease transmission across a range of transmission intensities.

13 April 2021 in eLife
Verified
Journal Article
Open access
AHAstrid Hoermann
Astrid Hoermann
STSofia Tapanelli
Sofia Tapanelli
PCPaolo Capriotti
Paolo Capriotti
GCGiuseppe Del Corsano
Giuseppe Del Corsano
EMEllen Kg Masters
Ellen Kg Masters
NWNikolai Windbichler
Nikolai Windbichler
Gene drives for mosquito population replacement are promising tools for malaria control. However, there is currently no clear pathway for safely testing such tools in endemic countries. The lack of well-characterized promoters for infection-relevant tissues and regulatory hurdles are further obstacles for their design and use. Here we explore how minimal genetic modifications of endogenous mosquito genes can convert them directly into non-autonomous gene drives without disrupting their expression. We co-opted the native regulatory sequences of three midgut-specific loci of the malaria vector Anopheles gambiae to host a prototypical antimalarial molecule and guide-RNAs encoded within artificial introns that support efficient gene drive. We assess the propensity of these modifications to interfere with the development of Plasmodium falciparum and their effect on fitness. Because of their inherent simplicity and passive mode of drive such traits could form part of an acceptable testing pathway of gene drives for malaria eradication.

2 June 2022 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
DEDavid A. Ellis
David A. Ellis
GAGeorge Avraam
George Avraam
AHAstrid Hoermann
Astrid Hoermann
CWClaudia A. S. Wyer
Claudia A. S. Wyer
YOYi Xin Ong
Yi Xin Ong
NWNikolai Windbichler
Nikolai Windbichler
Gene drives for mosquito population modification are novel tools for malaria control. Strategies to safely test antimalarial effectors in the field are required. Here, we modified the Anopheles gambiae zpg locus to host a CRISPR/Cas9 integral gene drive allele (zpgD) and characterized its behaviour and resistance profile. We found that zpgD dominantly sterilizes females but can induce efficient drive at other loci when it itself encounters resistance. We combined zpgD with multiple previously characterized non-autonomous payload drives and found that, as zpgD self-eliminates, it leads to conversion of mosquito cage populations at these loci. Our results demonstrate how self-eliminating drivers could allow safe testing of non-autonomous effector-traits by local population modification. They also suggest that after engendering resistance, gene drives intended for population suppression could nevertheless serve to propagate subsequently released non-autonomous payload genes, allowing modification of vector populations initially targeted for suppression.

10 December 2025 in Nature
Verified
Journal Article
Open access
PDF file
THTibebu Habtewold
Tibebu Habtewold
DLDickson Wilson Lwetoijera
Dickson Wilson Lwetoijera
AHAstrid Hoermann
Astrid Hoermann
RMRajabu Mashauri
Rajabu Mashauri
FMFatuma Matwewe
Fatuma Matwewe
GCGeorge K. Christophides
George K. Christophides
Gene drive technology presents a transformative approach to combatting malaria by introducing genetic modifications into wild mosquito populations to reduce their vectorial capacity. Although effective modifications have been developed, these efforts have been confined to laboratories in the global north. We previously demonstrated that modifying Anopheles gambiae to express two exogenous antimicrobial peptides inhibits the sporogonic development of laboratory-cultured Plasmodium falciparum , with models predicting substantial contributions to malaria elimination in Africa when integrated with gene drive 1–3 . However, the effectiveness of this modification against genetically diverse, naturally circulating parasite isolates remained unknown. To address this critical gap, we adapted our technology for an African context by establishing infrastructural and research capacity in Tanzania, enabling the engineering of local A. gambiae under containment. Here we report the generation of a transgenic strain equipped with non-autonomous gene drive capabilities that robustly inhibits genetically diverse P. falciparum isolates obtained from naturally infected children. These genetic modifications were efficiently inherited by progeny when supplemented with Cas9 endonuclease provided by another locally engineered strain. Our work brings gene drive technology a critical step closer to application, providing a locally tailored and powerful tool for malaria eradication through the targeted dissemination of beneficial genetic traits in wild mosquito populations.

25 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SVSebald A. N. Verkuijl
Sebald A. N. Verkuijl
GCGiuseppe Del Corsano
Giuseppe Del Corsano
PCPaolo Capriotti
Paolo Capriotti
PYPei-Shi Yen
Pei-Shi Yen
MIMaria Grazia Inghilterra
Maria Grazia Inghilterra
NWNikolai Windbichler
Nikolai Windbichler
Gene drive technology presents a promising approach to controlling malaria vector populations. Suppression drives are intended to disrupt essential mosquito genes whereas modification drives aim to reduce the individual vectorial capacity of mosquitoes. Here we present a highly efficient homing gene drive in the African malaria vector Anopheles gambiae that targets the microRNA gene mir-184 and combines suppression with modification. Homozygous gene drive (miR-184D) individuals incur significant fitness costs, including high mortality following a blood meal, that curtail their propensity for malaria transmission. We attribute this to a role of miR-184 in regulating solute transport in the mosquito gut. However, females remain fully fertile, and pure-breeding miR-184D populations suitable for large-scale releases can be reared under laboratory conditions. Cage invasion experiments show that miR-184D can spread to fixation thereby reducing population fitness, while being able to propagate a separate antimalarial effector gene at the same time. Modelling indicates that the miR-184D drive integrates aspects of population suppression and population replacement strategies into a candidate strain that should be evaluated further as a tool for malaria eradication.

30 April 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
CUChiamaka Valerie Ukegbu
Chiamaka Valerie Ukegbu
MMMgeni Mohamed
Mgeni Mohamed
AHAstrid Hoermann
Astrid Hoermann
YQYuyan Qin
Yuyan Qin
PKPrisca A. Kweyamba
Prisca A. Kweyamba
DVDina Vlachou
Dina Vlachou
The transition from ookinete to oocyst is a critical step in the Plasmodium falciparum lifecycle and an important target for malaria transmission-blocking strategies. PfPIMMS43, a surface protein of P. falciparum ookinetes and sporozoites, is critical for this transition and aids the parasite in evading mosquito immune responses. Previous studies demonstrated that polyclonal PfPIMMS43 antibodies reduced P. falciparum infection in Anopheles mosquitoes. Here, building on these findings, we have developed high-affinity single-domain VHH antibodies (nanobodies) derived from llama heavy-chain-only antibodies. We have shown that these nanobodies bind both recombinant and endogenous PfPIMMS43 produced by P. falciparum ookinetes in the mosquito midgut. Importantly, they significantly reduce infection intensity and prevalence of laboratory and field strains of P. falciparum in An. coluzzii and An. gambiae, respectively. Epitope mapping has revealed that the nanobodies target conserved regions in the second half of PfPIMMS43, with homology modelling confirming epitope accessibility. These findings establish PfPIMMS43 as a promising transmission-blocking target. To enhance malaria control and elimination efforts, we propose an innovative strategy in which genetically modified mosquitoes express PfPIMMS43-specific nanobodies in their midguts and spread this trait in wild mosquito populations via gene drive technology.